Minnesota State was advised on April 18 that the United States Anti-Doping Agency would be announcing a six-month suspension for Dryden McKay as a result of positive drug test that occurred in late January while he was preparing for a possible opportunity to represent Team USA in the 2022 Beijing Winter Olympic Games.

McKay was tested Jan. 23 and learned of the positive test on Jan. 31. He received a mandatory provisional suspension Feb. 3 that was lifted the same day by an arbitrator after an evidentiary hearing.

And while as an institution we operate completely outside of the USADA process and timeline, we naturally recognized our obligation to determine Dryden’s eligibility for NCAA competition.  With appropriate due diligence, we were able to quickly confirm with the NCAA that as a result of the arbitrator’s decision to lift the suspension, Dryden remained eligible for competition and that was the case throughout the remainder of the season, which concluded with an NCAA championship appearance on April 9.

Despite USADA’s decision to re-open the case and impose a suspension we continue to believe Dryden McKay is an impressive young man, with unquestionable character and integrity who was unequivocally committed to the standards of fairness that come with competing drug free.

After four incredible years with Maverick hockey Dryden is transitioning to another stage in his life and we want to wish him well in his future personal and professional endeavors and, as such, we will defer any further comment on this situation.

Kevin Buisman

Director of Athletics